Date: Thursday, November 6, 2008
Time: 5:30 - 6:30PM (reception to follow)
Location: CSEB Auditorium B17

St. Jude Medical was twice named as a “Top 50″ performing large company by BusinessWeek during Mark Kroll’s tenure as CTO (Chief Technology Officer) and Sr. VP. Now, he serves as corporate director of Haemonetics (NYSE:HAE), Taser International (NASD:TASR), NewCardio (BB:NWCI) and numerous private companies.

Serving on numerous faculty positions, Mark Kroll is also listed in the Who’s Who In Science And Engineering since 1992. He was awarded “Fellow” recognition by the American College of Cardiology and the Heart Rhythm Society. Co-editor of 3 books, and author of over 200 papers, invited presentations, book chapters, and abstracts.

Mark Kroll earned his B.S. Mathematics (University of Minnesota), M.S. and Ph.D. in Electrical Engineering (University of Minnesota), and M.B.A. (University of St. Thomas). His research specialty is the effects of electricity on the human body. Holding over 275 issued U.S. patents, Mark Kroll is honored by the U.S. Patent and Trademark Office as most prolific inventor of electrical medical devices in the world. Indeed, over 1 million human beings have his patents in their bodies.

Time: 6:30 pm
Location: Johns Hopkins School of Medicine, Pre-Clinical Teaching Building (PCTB), West Lecture Hall.

Dr. David Hungerford invented the Duracon Total Knee Replacement technology, which has been implanted in approximately 3 million patients. He is currently a Professor in the Department of Orthopaedic Surgery at the Johns Hopkins University. In his talk, entitled “Medical Device Innovation: Total Knee Replacement as a Case Study,” Dr. Hungerford spoke about the commercialization path that he pursued and also provided some pearls of wisdom regarding creativity and device innovation

Time: 6:00 pm
Location: Homewood Campus, Hodson 210

Mr. Rogelio Rodriguez shares his experiences in medical device development. He received his B.S. in Engineering from California State University, Fullerton and his M.S. in Engineering from California State University, Long Beach. His master’s thesis was entitled, “Cardiac Bioelectric Activity: Real-Time Simulation of Electrocardiogram.” He currently serves as the Director of Engineering Science Programs at UC Irvine, where his functional role is to address the workforce and the professional development needs of scientific and engineering professionals, and to lead program development for continuing education.

Download:

• Case Study
• Key Definitions
• PowerPoint Slides

Time: 5:30 pm
Location: Homewood Campus, Computational Science and Engineering Building (CSEB), Room B17

Dr. Fred Burbank, currently the Medical Director of Salt Creek Ventures, has founded three successful medical device companies – Biopsys (acquired by Johnson & Johnson), Vascular Control Systems, and SenoRx. After he received his M.D. from the Stanford School of Medicine, Dr. Burbank completed an internship in Internal Medicine, residencies in Psychiatry and Diagnostic Radiology, and a fellowship in Interventional Radiology. In his talk, he focused on one company “Vascular Control System”, and he discussed the challenges associated with starting a medical device company and with being an entrepreneur, and how his background assisted him along his career path.

Time: 5:30 pm
Location: Homewood Campus, Clark 110

Dr. Mohit Kaushal is a Venture Associate from the Boston division of Medtronic, where he performs technology scouting duties for the Medicine and Technology group, which is overseen by Dr. Stephen Oesterle. In addition, Dr. Kaushal joined Polaris Venture Partners in September 2007 as a full time employee, where he focuses on investments in the life sciences and spends a significant amount of time concentrating on European health-care opportunities. Prior to obtaining his MBA from the Stanford Graduate School of Business, Dr. Kaushal earned his Medical Degree from the Imperial College of Science, Technology, and Medicine. In his talk, Dr. Kaushal presented a venture capitalist’s perspective on transitioning technology into the marketplace.